An exchange-traded fund that provides concentrated exposure to large-cap biotechnology companies listed in the United States. The fund tracks a rules-based index of leading biotech firms involved in the development of novel therapeutics, with holdings often dominated by established drug developers a...
2 members of Congress have disclosed 3 trades in VanEck Biotech ETF (BBH), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-04 | Thomas Suozzi | sell | $50K – $100K |
| 2022-01-28 | Donald Sternoff Beyer | sell | $1K – $15K |
| 2021-12-22 | Donald Sternoff Beyer | buy | $1K – $15K |